152 related articles for article (PubMed ID: 8887487)
21. Identification of HCV core mimotopes: improved methods for the selection and use of disease-related phage-displayed peptides.
Tafi R; Bandi R; Prezzi C; Mondelli MU; Cortese R; Monaci P; Nicosia A
Biol Chem; 1997 Jun; 378(6):495-502. PubMed ID: 9224929
[TBL] [Abstract][Full Text] [Related]
22. Generation of chicken single chain antibody variable fragments (scFv) that differentiate and neutralize infectious bursal disease virus (IBDV).
Sapats SI; Heine HG; Trinidad L; Gould GJ; Foord AJ; Doolan SG; Prowse S; Ignjatovic J
Arch Virol; 2003 Mar; 148(3):497-515. PubMed ID: 12607101
[TBL] [Abstract][Full Text] [Related]
23. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.
Cerino A; Boender P; La Monica N; Rosa C; Habets W; Mondelli MU
J Immunol; 1993 Dec; 151(12):7005-15. PubMed ID: 7505020
[TBL] [Abstract][Full Text] [Related]
24. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
Ansari MA; Irshad M; Agarwal SK; Chosdol K
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
[TBL] [Abstract][Full Text] [Related]
25. HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection.
Jolivet-Reynaud C; Dalbon P; Viola F; Yvon S; Paranhos-Baccala G; Piga N; Bridon L; Trabaud MA; Battail N; Sibai G; Jolivet M
J Med Virol; 1998 Dec; 56(4):300-9. PubMed ID: 9829633
[TBL] [Abstract][Full Text] [Related]
26. A phage-displayed single chain variable fragment that interacts with hepatitis B core antigen: library construction, selection and diagnosis.
Tan GH; Yusoff K; Seow HF; Tan WS
J Clin Virol; 2007 Jan; 38(1):49-56. PubMed ID: 17074533
[TBL] [Abstract][Full Text] [Related]
27. Characterisation of a panel of monoclonal antibodies raised against recombinant HCV core protein.
Ferns RB; Tuke PW; Sweenie CH
J Med Virol; 1996 Nov; 50(3):221-9. PubMed ID: 8923286
[TBL] [Abstract][Full Text] [Related]
28. Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia.
Gabrielli A; Zhang ZX; Cherubini G; Candela M; Savoldi S; Manzin A; Clementi M; Amoroso A; Sallberg M
Clin Exp Immunol; 1996 Jul; 105(1):59-64. PubMed ID: 8697636
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.
Steinmann D; Barth H; Gissler B; Schürmann P; Adah MI; Gerlach JT; Pape GR; Depla E; Jacobs D; Maertens G; Patel AH; Inchauspé G; Liang TJ; Blum HE; Baumert TF
J Virol; 2004 Sep; 78(17):9030-40. PubMed ID: 15308699
[TBL] [Abstract][Full Text] [Related]
30. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
[TBL] [Abstract][Full Text] [Related]
31. Human monoclonal recombinant Fabs specific for HCV antigens obtained by repertoire cloning in phage display combinatorial vectors.
Plaisant P; Burioni R; Manzin A; Solforosi L; Candela M; Gabrielli A; Fadda G; Clementi M
Res Virol; 1997; 148(2):165-9. PubMed ID: 9108620
[TBL] [Abstract][Full Text] [Related]
32. A bidirectional phage display vector for the selection and mass transfer of polyclonal antibody libraries.
Den W; Sompuram SR; Sarantopoulos S; Sharon J
J Immunol Methods; 1999 Jan; 222(1-2):45-57. PubMed ID: 10022371
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.
Mancini N; Canducci F; Carletti S; Berardinelli E; Serafini G; Grieco A; Perotti M; Malcangi G; Danieli MG; Varaldo PE; Clementi M; Burioni R
J Biol Regul Homeost Agents; 2003; 17(2):183-7. PubMed ID: 14518720
[TBL] [Abstract][Full Text] [Related]
34. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
[TBL] [Abstract][Full Text] [Related]
36. Establishment of human clones producing neutralizing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus by EBV immortalization of immune CD22⁺ B cells.
Tabll A; El Abd Y; El Din NG; El Shenawy R; Abdelhafez TH; El Awady M; El-Mohamady H; Viazov S
Hum Antibodies; 2013; 22(3-4):55-65. PubMed ID: 24961863
[TBL] [Abstract][Full Text] [Related]
37. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
Zibert A; Schreier E; Roggendorf M
Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
[TBL] [Abstract][Full Text] [Related]
38. Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries.
Bugli F; Mancini N; Kang CY; Di Campli C; Grieco A; Manzin A; Gabrielli A; Gasbarrini A; Fadda G; Varaldo PE; Clementi M; Burioni R
J Virol; 2001 Oct; 75(20):9986-90. PubMed ID: 11559832
[TBL] [Abstract][Full Text] [Related]
39. Highly efficient selection of phage antibodies mediated by display of antigen as Lpp-OmpA' fusions on live bacteria.
Benhar I; Azriel R; Nahary L; Shaky S; Berdichevsky Y; Tamarkin A; Wels W
J Mol Biol; 2000 Aug; 301(4):893-904. PubMed ID: 10966794
[TBL] [Abstract][Full Text] [Related]
40. Characterization and binding of intracellular antibody fragments to the hepatitis C virus core protein.
Heintges T; zu Putlitz J; Wands JR
Biochem Biophys Res Commun; 1999 Sep; 263(2):410-8. PubMed ID: 10491307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
